
Glucoryl MV 2 mg Tablet
Salt Composition: Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Expiry Date: 01/2028
Inclusive of all taxes
15 Tablet
About The Product
Used To Control Fasting And Post-Meal Blood Sugar Levels
Description
Glucoryl MV 2 mg Tablet is an anti-diabetic medicine. It is a combination of Glimepiride (2mg), Met4formin (500mg) and Voglibose (0.2mg).
It is prescribed to treat type 2 diabetes mellitus in adults. It works by controlling blood sugar levels in people with diabetes.
It should be taken with food at the same time each day to get effective results. Don't take more than the recommended dose
Uses
- Type 2 diabetes mellitus
Side Effects
Glucoryl MV 2 mg Tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
Seek medical attention in case of any unusual or severe side effects immediately.
How To Use
- Take Glucoryl MV 2 mg Tablet in dosage as prescribed by the doctor.
- Dosage and the duration determined as per the patients health condition.
- This tablet should be swallowed as a whole with water.
- Don't crush, chew, or break the tablet.
- It should be taken with food.
- Never skip a dose or double dose.
How It Works
- Glucoryl MV 2 mg Tablet is an anti-diabetic medicine. It is a combination of Glimepiride (2mg), Metformin (500mg) and Voglibose (0.2mg). As a sulfonylurea, glimepiride minimizes blood sugar by stimulating the pancreas to secrete more insulin.
- Metformin is a biguanide that increases the body's tolerance to insulin, reduces the liver's synthesis of glucose, and slows down the intestines' absorption of glucose.
- Alpha-glucosidase inhibitors like voglibose prevent complex sugars from breaking down into simple sugars like glucose. As a result, this medicine prevents blood glucose levels from rising to extremely high levels immediately after meals.
Safety Advice
FAQs
Glucoryl MV 2 mg Tablet is consist of three anti-diabetic medicines such as Glimepiride (2mg), Metformin (500mg) and Voglibose (0.2mg).
References
- Tanaka, K., Okada, Y., Umezu, S., Hashimoto, R., Tomoyose, Y., Tateyama, R. ... & Tanaka, Y. (2024). Comparative effects of fixed‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial. Journal of Diabetes Investigation, 15(4), 449-458. https://pubmed.ncbi.nlm.nih.gov/38149694/
- Jindal, A., Gupta, M., Sharma, G., Mohan, G., & Tikoo, D. (2012). Comparative evaluation of voglibose versus pioglitazone on glycaemic control and lipid profile in patients of type 2 diabetes mellitus on glimepiride and metformin in Punjabi population. Int J Basic Clin Pharmacol, 1(3), 160-7. https://www.researchgate.net/publication/269918536_Comparative_evaluation_of_voglibose_versus_pioglitazone_on_glycaemic_control_and_lipid_profile_in_patients_of_type_2_diabetes_mellitus_on_glimepiride_and_metformin_in_punjabi_population
- Suman, S. V. (2020). Efficacy and Safety of Voglibose Vs Glimepride in Combination with Metformin in Type 2 Diabetes: A randomized Controlled Trial (Doctoral dissertation).
- Faruqui, A. A. (2016). Safety and efficacy of fixed dose combination of voglibose, glimepiride and metformin in Indian type 2 diabetes mellitus patients. Age (yrs), 36, 78. https://www.researchgate.net/publication/346988980_Safety_and_Efficacy_of_Fixed_Dose_Combination_of_Voglibose_Glimepiride_and_Metformin_in_Indian_Type_2_Diabetes_Mellitus_Patients
- BANTWAL, G., AYYAR, V., KOVIL, R., CHAWLA, M., SHAH, T., KUMAR, S. ... & REVANKAR, S. (2021). Assessment of Clinical Experience of Triple Drug Fixed-dose Combination of Glimepiride, Metformin and Voglibose in the Management of Type 2 Diabetes Mellitus: A Retrospective Study. Journal of Clinical & Diagnostic Research, 15(9). https://www.researchgate.net/publication/357481699_Assessment_of_Clinical_Experience_of_Triple_Drug_Fixed-dose_Combination_of_Glimepiride_Metformin_and_Voglibose_in_the_Management_of_Type_2_Diabetes_Mellitus_A_Retrospective_Study
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
